A Prospective Study to Evaluate the Performance of a Real-time System in the Estimation of Colorectal Polyp Size
Sponsor: Chinese University of Hong Kong
Trial Details
| Condition | Colonic Polyps, CRC (Colorectal Cancer), Artificial Intelligence (AI) |
| Intervention | EndoAIM |
| Phase | NA |
| Status | Recruiting |
| Participants | 278 |
| Est. Completion | 1 May 2027 |
| Last Updated | 23 Apr 2026 |
Primary Outcome
The primary endpoint is the difference in percentage for each measurement in discriminating polyp size at the 10mm threshold
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: Subjects are eligible if: 1. They have received colonoscopy for screening, surveillance or symptom investigation; 2. Aged 18 years older or above; 3. Written informed consent obtained. Exclusion Criteria: Subjects are excluded if they have: 1. Contraindication to colonoscopy (e.g. intestinal obstruction or perforation) 2. Contraindication or conditions precluding polyp resection (e.g. active gastrointestinal bleeding, uninterrupted anticoagulation or dual antiplatelets) 3. Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above)
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service